Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 64505 [2013-25427]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 209 / Tuesday, October 29, 2013 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–25428 Filed 10–28–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces, the following meeting of the
aforementioned committee:
Time and Date: 8:30 a.m.–4:30 p.m.
Eastern Time, November 15, 2013.
Place: Teleconference.
Status: The meeting is open to the public;
the toll free dial in number is 1–877–937–
9818 and the passcode is 7551384.
Purpose: The board makes
recommendations regarding policies,
strategies, objectives, and priorities, and
reviews progress toward injury prevention
goals and provides evidence in injury
prevention-related research and programs.
The board provides advice on the appropriate
balance of intramural and extramural
research, and provides advice on the
structure, progress and performance of
intramural programs. The Board of Scientific
Counselors is also designed to provide
guidance on extramural scientific program
matters, including the: (1) Review of
extramural research concepts for funding
opportunity announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements, and
contracts applications received in response to
the funding opportunity announcements as it
relates to the Center’s programmatic balance
and mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered for
funding support; (4) review of research
portfolios, and (5) review of program
proposals. The board shall provide guidance
on the National Center of Injury Prevention
and Control’s programs and research
activities by conducting scientific peer
review of intramural research and programs
within the National Center for Injury
Prevention and Control; by ensuring
adherence to Office of Management and
Budget requirements for intramural peer
review; and by monitoring the overall
direction, focus, and success of the National
Center for Injury Prevention and Control.
Matters to be Discussed: The BSC, NCIPC
will discuss the recommendations provided
by the expert panel on the Health
VerDate Mar<15>2010
18:15 Oct 28, 2013
Jkt 232001
Communication Portfolio Review that has
been conducted and to discuss research
strategies needed to guide the Center’s focus.
The BSC members will also discuss potential
topics for the upcoming Portfolio Review.
There will be 15 minutes allotted for public
comments at the end of the open session.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D., M.S.E.H.,
Designated Federal Official, NCIPC, CDC,
4770 Buford Highway NE., Mailstop F–63,
Atlanta, Georgia 30341, Telephone: (770)
488–1430.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–25427 Filed 10–28–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0001]
Request for Nominations for Voting
Members on a Public Advisory
Committee; Tobacco Products
Scientific Advisory Committee
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is requesting
nominations for voting members to
serve on the Tobacco Products Scientific
Advisory Committee, Office of Science,
Center for Tobacco Products.
FDA seeks to include the views of
women and men, members of all racial
and ethnic groups, and individuals with
and without disabilities on its advisory
committees and, therefore, encourages
nominations of appropriately qualified
candidates from these groups.
DATES: Nominations received on or
before December 30, 2013, will be given
first consideration for membership on
the Tobacco Products Scientific
Advisory Committee. Nominations
received after December 30, 2013, will
be considered for nomination to the
committee as later vacancies occur.
ADDRESSES: All nominations for
membership should be sent
electronically to cv@oc.fda.gov or by
SUMMARY:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
64505
mail to Advisory Committee Oversight
and Management Staff, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 32, Rm. 5103, Silver Spring,
MD 20993–0002.
FOR FURTHER INFORMATION CONTACT:
Regarding all nomination questions for
membership, the primary contact is:
Caryn Cohen, Office of Science, Center
for Tobacco Products, Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850, 1–877–287–1373
(choose Option 5), FAX: 240–276–3655,
email: TPSAC@fda.hhs.gov.
Information about becoming a
member on an FDA advisory committee
can also be obtained by visiting FDA’s
Web site by using the following link:
https://www.fda.gov/Advisory
Committees/default.htm.
SUPPLEMENTARY INFORMATION: FDA is
requesting nominations for voting
members on the Tobacco Products
Scientific Advisory Committee.
Elsewhere in this issue of the Federal
Register, FDA is publishing a separate
document announcing the Request for
Nominations for Nonvoting Industry
Representatives on the Tobacco
Products Scientific Advisory
Committee.
I. General Description of the Committee
Duties
The Tobacco Products Scientific
Advisory Committee advises the
Commissioner or designee in
discharging responsibilities as they
relate to the regulation of tobacco
products. The Committee reviews and
evaluates safety, dependence, and
health issues relating to tobacco
products and provides appropriate
advice, information, and
recommendations to the Commissioner
of Food and Drugs.
II. Criteria for Voting Members
The Committee shall consist of 12
members including the Chair. Members
and the Chair are selected by the
Commissioner or designee from among
individuals knowledgeable in the fields
of medicine, medical ethics, science, or
technology involving the manufacture,
evaluation, or use of tobacco products.
Members will be invited to serve for
overlapping terms of up to 4 years.
Almost all non-Federal members of this
committee serve as Special Government
Employees. The Committee shall
include nine technically qualified
voting members, selected by the
Commissioner or designee. The nine
voting members shall be physicians,
dentists, scientists, or health care
professionals practicing in the area of
oncology, pulmonology, cardiology,
E:\FR\FM\29OCN1.SGM
29OCN1
]]>Agencies
[Federal Register Volume 78, Number 209 (Tuesday, October 29, 2013)]
[Notices]
[Page 64505]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25427]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC)
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces, the following meeting of the aforementioned
committee:
Time and Date: 8:30 a.m.-4:30 p.m. Eastern Time, November 15,
2013.
Place: Teleconference.
Status: The meeting is open to the public; the toll free dial in
number is 1-877-937-9818 and the passcode is 7551384.
Purpose: The board makes recommendations regarding policies,
strategies, objectives, and priorities, and reviews progress toward
injury prevention goals and provides evidence in injury prevention-
related research and programs. The board provides advice on the
appropriate balance of intramural and extramural research, and
provides advice on the structure, progress and performance of
intramural programs. The Board of Scientific Counselors is also
designed to provide guidance on extramural scientific program
matters, including the: (1) Review of extramural research concepts
for funding opportunity announcements; (2) conduct of Secondary Peer
Review of extramural research grants, cooperative agreements, and
contracts applications received in response to the funding
opportunity announcements as it relates to the Center's programmatic
balance and mission; (3) submission of secondary review
recommendations to the Center Director of applications to be
considered for funding support; (4) review of research portfolios,
and (5) review of program proposals. The board shall provide
guidance on the National Center of Injury Prevention and Control's
programs and research activities by conducting scientific peer
review of intramural research and programs within the National
Center for Injury Prevention and Control; by ensuring adherence to
Office of Management and Budget requirements for intramural peer
review; and by monitoring the overall direction, focus, and success
of the National Center for Injury Prevention and Control.
Matters to be Discussed: The BSC, NCIPC will discuss the
recommendations provided by the expert panel on the Health
Communication Portfolio Review that has been conducted and to
discuss research strategies needed to guide the Center's focus. The
BSC members will also discuss potential topics for the upcoming
Portfolio Review. There will be 15 minutes allotted for public
comments at the end of the open session.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Gwendolyn H. Cattledge,
Ph.D., M.S.E.H., Designated Federal Official, NCIPC, CDC, 4770
Buford Highway NE., Mailstop F-63, Atlanta, Georgia 30341,
Telephone: (770) 488-1430.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-25427 Filed 10-28-13; 8:45 am]
BILLING CODE 4163-18-P
